www.fdanews.com/articles/68474-japan-s-takeda-buys-california-biotechnology-company-for-us-270-million
Japan's Takeda Buys California Biotechnology Company for US$270 Million
February 7, 2005
Japan's largest drugmaker, Takeda Pharmaceutical, will acquire Syrrx, a privately held California biotechnology company working on treatments for cancer and diabetes, for roughly US$270 million in cash. The purchase will give Takeda access to high-level talent and new medical research innovations. The Japanese company was also eager to have a research base in the U.S., the world's largest pharmaceutical market and a center for medical research.